Metastatic Colorectal Cancers Completed Phase 2 Trials for Everolimus (DB01590)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01387880Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal CancerTreatment